Management of multiple sclerosis through Ayurveda: A case report

S. Gupta, Latika Kundra, R. Yadava, Prasanth Dharmarajan
{"title":"Management of multiple sclerosis through Ayurveda: A case report","authors":"S. Gupta, Latika Kundra, R. Yadava, Prasanth Dharmarajan","doi":"10.4103/jacr.jacr_64_20","DOIUrl":null,"url":null,"abstract":"Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problem between brain and rest of the body. Steroids are the drugs of choice in conventional systems but fail to provide a complete cure. There is no direct reference to the disease in Ayurveda, but based on the clinical picture, treatment can be planned. A 28-year-old male patient diagnosed with MS approached the Panchakarma outpatient department with chief complaints of difficulty in balancing while standing and walking, weakness in bilateral lower limbs, and lower backache. On examination of presentation according to Ayurveda, this manifestation was diagnosed as a type of Vata vyadhi (~diseases caused by a Vata dosha). Considering the case, different Panchakarma (~five bio-purification therapies) procedures including Ruksha churna pinda swedana (~dry fomentation), Takradhara (~therapeutic buttermilk dripping), Kshara basti (~therapeutic enema therapy by alkali substance), Snehapana (~internal administration of medicated lipids), and Virechana (~therapeutic purgation) followed by Kalabasti (~therapeutic enema therapy) and Nasya (~intranasal drug administration) were adopted along with Shamana (~palliative) therapy. After completion of 45-day stay in hospital and one month Shamana treatment on follow-up, considerable improvement was recorded in subjective parameters. Assessments were made using the Kurtzke Expanded Disability Status Scale which was 8 before treatment and decreased to three after follow-up. The Functional Assessment of MS was reduced from 158 to 102. The Visual Analog Scale which was 8 before treatment was decreased to 1 with increased quality of life according to the SF-36 Quality of Life Scale.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jacr.jacr_64_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problem between brain and rest of the body. Steroids are the drugs of choice in conventional systems but fail to provide a complete cure. There is no direct reference to the disease in Ayurveda, but based on the clinical picture, treatment can be planned. A 28-year-old male patient diagnosed with MS approached the Panchakarma outpatient department with chief complaints of difficulty in balancing while standing and walking, weakness in bilateral lower limbs, and lower backache. On examination of presentation according to Ayurveda, this manifestation was diagnosed as a type of Vata vyadhi (~diseases caused by a Vata dosha). Considering the case, different Panchakarma (~five bio-purification therapies) procedures including Ruksha churna pinda swedana (~dry fomentation), Takradhara (~therapeutic buttermilk dripping), Kshara basti (~therapeutic enema therapy by alkali substance), Snehapana (~internal administration of medicated lipids), and Virechana (~therapeutic purgation) followed by Kalabasti (~therapeutic enema therapy) and Nasya (~intranasal drug administration) were adopted along with Shamana (~palliative) therapy. After completion of 45-day stay in hospital and one month Shamana treatment on follow-up, considerable improvement was recorded in subjective parameters. Assessments were made using the Kurtzke Expanded Disability Status Scale which was 8 before treatment and decreased to three after follow-up. The Functional Assessment of MS was reduced from 158 to 102. The Visual Analog Scale which was 8 before treatment was decreased to 1 with increased quality of life according to the SF-36 Quality of Life Scale.
阿育吠陀治疗多发性硬化症1例
多发性硬化症(MS)是一种潜在的大脑和脊髓(中枢神经系统)致残疾病。在多发性硬化症中,免疫系统攻击覆盖神经纤维的保护鞘(髓鞘),导致大脑和身体其他部位之间的沟通问题。类固醇是常规系统的首选药物,但不能提供完全治愈。阿育吠陀没有直接提到这种疾病,但根据临床情况,可以计划治疗。一名确诊为多发性硬化症的28岁男性患者来到Panchakarma门诊,主诉为站立和行走时平衡困难,双侧下肢无力,腰痛。根据阿育吠陀的说法,这种表现被诊断为一种Vata vyadhi(由Vata dosha引起的疾病)。考虑到这种情况,不同的Panchakarma(~五种生物净化疗法)程序包括Ruksha churna pinda swedana(~干发酵)、Takradhara(~治疗性酪乳滴注)、Kshara basti(~碱物质治疗性灌肠疗法)、Snehapana(~内给脂类药物)、采用Virechana(~治疗性净化)、Kalabasti(~治疗性灌肠)、Nasya(~鼻内给药)联合Shamana(~姑息治疗)治疗。在完成45天的住院治疗和随访1个月的沙玛纳治疗后,主观参数有相当大的改善。采用Kurtzke扩展残疾状态量表进行评估,治疗前为8分,随访后降至3分。MS的功能评估从158降至102。根据SF-36生活质量量表,治疗前的视觉模拟评分为8分,随着生活质量的提高,视觉模拟评分降至1分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信